Rapid reduction of antihypertensive medications and insulin requirements after tracheostomy in a patient with severe obstructive sleep apnea syndrome

Journal of Clinical Sleep Medicine

Volumn 3, Issue 3, 2007, Pages 297-299

  Bhimaraj, Arvind ^a   Havaligi, Navasuma ^a   Ramachandran, Siva ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Sleep Wellness Center of Pottstown   (United States)

Author keywords

Hypertension; Insulin resistance; Sleep apnea

Indexed keywords

AMLODIPINE; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; CARVEDILOL; FUROSEMIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; INSULIN ASPART; INSULIN GLARGINE; IRBESARTAN; ISOPHANE INSULIN; ISOSORBIDE MONONITRATE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DIABETES MELLITUS; DRUG DOSE REDUCTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; MALE; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE COMPLICATION; SEPSIS; SLEEP APNEA SYNDROME; TRACHEOSTOMY;

EID: 34248529865     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.26803     Document Type: Article

References (16)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstrucive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39.
2. Robinson GV, Stradling JR, Davies RJ. Obstructive sleep apnea/hypopnea syndrome and hypertension. Thorax 2004;59:1089-94.
3. Hamilton GS, Solin P, Naughton MT. Obstructive sleep apnea and cardiovascular disease. Intern Med J 2004;34:420-6.
4. Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA, O'Donnell CP. Sleep-disordered breathing, glucose intolerance and insulin resistance. Respir Physiol Neurobiol 2003;136:167-78.
5. Punjabi NM. Shahar E. Redline S, Gottlieb DJ, Givelber R, Resnick; Sleep Heart Health Study Investigators. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160:521-30.
6. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994;79:1681-85.
7. Cooper BG, White JE, Ashworth LA, Alberti KG, Gibson GJ. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 1995;18:172-9.
8. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004;169:156-62.
9. Babu AR, Herdegen J, Fogelfeld L, Short S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005;165:447-52.
10. Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in obstructive sleep apnea and hypertension. Sleep 1987;10:35-44
11. Guilleminault C, Simmons FB, Motta J, et al. Obstructive sleep apnea syndrome and tracheostomy:long term follow up experience. Arch Intern Med 1981; 141: 985-8.
12. Sher AE. Upper airway surgery for obstructive sleep apnea. Sleep Med Rev 2002; 6:195-212.
13. Dimsdale JE, Coy T, Ziegler MG, et al. The effect of sleep apnea on plasma and urinary catecholamines. Sleep 1995;18:377-81.
14. Aoki M, Nata T, Morishita R, et al. Endothelial apoptosis induced by oxidative stress through activation of NF-kB: Antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 2001; 38:48-55.
15. Phelan MW, Faller DV. Hypoxia decreases constitutive nitric oxide synthase transcript and protein in cultured endothelial cells. J Cell Physiol 1996; 167:469-76.
16. Kanagy NL, Walker BR, Nelin LD. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 2001;37:511-15.